Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A multi-country analysis of COVID-19 hospitalizations by vaccination status

  • Gonçalves, Bronner P.
  • Martin-Loeches, Ignacio
  • Merson, Laura
  • ISARIC Clinical Characterisation Group
Background. Individuals vaccinated against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), when infected, can still develop disease that requires hospitalization. It remains unclear whether these patients differ from hospitalized unvaccinated patients with regard to presentation, coexisting comorbidities, and outcomes. Methods. Here, we use data from an international consortium to study this question and assess whether differences between these groups are context specific. Data from 83,163 hospitalized COVID-19 patients (34,843 vaccinated, 48,320 unvaccinated) from 38 countries were analyzed. Findings. While typical symptoms were more often reported in unvaccinated patients, comorbidities, including some associated with worse prognosis in previous studies, were more common in vaccinated patients. Considerable between-country variation in both in-hospital fatality risk and vaccinated-versus-unvaccinated difference in this outcome was observed. Conclusions. These findings will inform allocation of healthcare resources in future surges as well as design of longer-term international studies to characterize changes in clinical profile of hospitalized COVID-19 patients related to vaccination history., This work was also funded by grants from the National Institute for Health Research (NIHR; award CO-CIN-01), the Medical Research Council (MRC; grant MC_PC_19059), and the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at the University of Liverpool in partnership with Public Health England (PHE) (award 200907), NIHR HPRU in Respiratory Infections at Imperial College London with PHE (award 200927), Liverpool Experimental Cancer Medicine Centre (grant C18616/A25153), NIHR Biomedical Research Centre at Imperial College London (award ISBRC-1215-20013), and NIHR Clinical Research Network providing infrastructure support; CIHR Coronavirus Rapid Research Funding Opportunity OV2170359 and the coordination in Canada by Sunnybrook Research Institute; funding by the Health Research Board of Ireland (CTN-2014-12); the Rapid European COVID-19 Emergency Response research (RECOVER) (H2020 project 101003589) and European Clinical Research Alliance on Infectious Diseases (ECRAID) (965313); Cambridge NIHR Biomedical Research Centre (award NIHR203312); a Research Council of Norway grant no. 312780 and a philanthropic donation from Vivaldi Invest A/S owned by Jon Stephenson von Tetzchner; the Comprehensive Local Research Networks (CLRNs), of which P.J.M.O. is an NIHR Senior Investigator (NIHR201385); Stiftungsfonds zur Förderung der Bekämpfung der Tuberkulose und anderer Lungenkrankheiten of the City of Vienna, project number APCOV22BGM; funding from Medical University of Vienna, Department of Anaesthesia, Intensive Care Medicine and Pain Medicine; Italian Ministry of Health “Fondi Ricerca corrente–L1P6” to IRCCS Ospedale Sacro Cuore–Don Calabria; Australian Department of Health grant (3273191); Gender Equity Strategic Fund at University of Queensland, Artificial Intelligence for Pandemics (A14PAN) at University of Queensland, the Australian Research Council Centre of Excellence for Engineered Quantum Systems (EQUS, CE170100009), the Prince Charles Hospital Foundation, Australia; a grant from foundation Bevordering Onderzoek Franciscus; the South Eastern Norway Health Authority and the Research Council of Norway; Institute of Cancer Research (ICR), National Institutes of Health (NIH) supported by the Ministry of Health Malaysia; and the US DoD Armed Forces Health Surveillance Division, Global Emerging Infectious Diseases Branch to the US Naval Medical ResearchUnit no. TWO (NAMRU-2) (Work Unit #: P0153_21_N2). These authors would like to thank Vysnova Partners, Inc., for the management of this research project. The Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit is funded by the Wellcome Trust; M.U.G.K. was supported by the Branco Weiss Fellowship, Google.org, the Oxford Martin School, the Rockefeller Foundation, and the European Union Horizon 2020 project MOOD (#874850). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The investigators acknowledge the support of the COVID clinical management team, AIIMS, Rishikesh, India; the COVID-19 Clinical Management team, Manipal Hospital Whitefield, Bengaluru, India; the Liverpool School of Tropical Medicine and the University of Oxford; Imperial NIHR Biomedical Research Centre; the dedication and hard work of the Norwegian SARS-CoV-2 study team; endorsement of the Irish Critical Care Clinical Trials Group, co-ordination in Ireland by the Irish Critical Care Clinical Trials Network at University College Dublin; and preparedness work conducted by the Short Period Incidence Study of Severe Acute Respiratory Infection. This work uses data provided by patients and collected by the NHS as part of their care and support #DataSavesLives. The data used for this research were obtained from ISARIC4C. We are extremely grateful to the 2,648 frontline NHS clinical and research staff and volunteer medical students who collected these data in challenging circumstances and for the generosity of the patients and their families for their individual contributions in these difficult times. The COVID-19 Clinical Information Network (CO-CIN) data were collated by ISARIC4C Investigators. We also acknowledge the support of Jeremy J. Farrar and Nahoko Shindo.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients

  • Gonçalves, Bronner P.
  • Gómez Junyent, Joan
  • Olliaro Piero L.
  • ISARIC Clinical Characterisation Group
Background: whilst timely clinical characterisation of infections caused by novel SARS-CoV-2 variants is necessary for evidence-based policy response, individual-level data on infecting variants are typically only available for a minority of patients and settings. Methods: here, we propose an innovative approach to study changes in COVID-19 hospital presentation and outcomes after the Omicron variant emergence using publicly available population-level data on variant relative frequency to infer SARS-CoV-2 variants likely responsible for clinical cases. We apply this method to data collected by a large international clinical consortium before and after the emergence of the Omicron variant in different countries. Results: our analysis, that includes more than 100,000 patients from 28 countries, suggests that in many settings patients hospitalised with Omicron variant infection less often presented with commonly reported symptoms compared to patients infected with pre-Omicron variants. Patients with COVID-19 admitted to hospital after Omicron variant emergence had lower mortality compared to patients admitted during the period when Omicron variant was responsible for only a minority of infections (odds ratio in a mixed-effects logistic regression adjusted for likely confounders, 0.67 [95% confidence interval 0.61-0.75]). Qualitatively similar findings were observed in sensitivity analyses with different assumptions on population-level Omicron variant relative frequencies, and in analyses using available individual-level data on infecting variant for a subset of the study population. Conclusions: although clinical studies with matching viral genomic information should remain a priority, our approach combining publicly available data on variant frequency and a multi-country clinical characterisation dataset with more than 100,000 records allowed analysis of data from a wide range of settings and novel insights on real-world heterogeneity of COVID-19 presentation and clinical outcome., Bronner P. Gonçalves, Peter Horby, Gail Carson, Piero L. Olliaro, Valeria Balan, Barbara Wanjiru Citarella, and research costs were supported by the UK Foreign, Commonwealth and Development Office (FCDO) and Wellcome [215091/Z/18/Z, 222410/Z/21/Z, 225288/Z/22/Z]; and Janice Caoili and Madiha Hashmi were supported by the UK FCDO and Wellcome [222048/Z/20/Z]. Peter Horby, Gail Carson, Piero L. Olliaro, Kalynn Kennon and Joaquin Baruch were supported by the Bill & Melinda Gates Foundation [OPP1209135]; Laura Merson was supported by University of Oxford's COVID-19 Research Response Fund - with thanks to its donors for their philanthropic support. Matthew Hall was supported by a Li Ka Shing Foundation award to Christophe Fraser. Moritz U.G. Kraemer was supported by the Branco Weiss Fellowship, Google.org, the Oxford Martin School, the Rockefeller Foundation, and the European Union Horizon 2020 project MOOD (#874850). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. Contributions from Srinivas Murthy, Asgar Rishu, Rob Fowler, James Joshua Douglas, François Martin Carrier were supported by CIHR Coronavirus Rapid Research Funding Opportunity OV2170359 and coordinated out of Sunnybrook Research Institute. Contributions from Evert-Jan Wils and David S.Y. Ong were supported by a grant from foundation Bevordering Onderzoek Franciscus; and Andrea Angheben by the Italian Ministry of Health "Fondi Ricerca corrente-L1P6" to IRCCS Ospedale Sacro Cuore-Don Calabria. The data contributions of J.Kenneth Baillie, Malcolm G. Semple, and Ewen M. Harrison were supported by grants from the National Institute for Health Research (NIHR; award CO-CIN-01), the Medical Research Council (MRC; grant MC_PC_19059), and by the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE) (award 200907), NIHR HPRU in Respiratory Infections at Imperial College London with PHE (award 200927), Liverpool Experimental Cancer Medicine Centre (grant C18616/A25153), NIHR Biomedical Research Centre at Imperial College London (award IS-BRC-1215-20013), and NIHR Clinical Research Network providing infrastructure support. All funders of the ISARIC Clinical Characterisation Group are listed in the appendix.
Repisalud
Publication Artículo de revisión (ReviewArticle)

A systematic review of environmental factors related to WNV circulation in European and Mediterranean countries

  • Giesen, Christine
  • Herrador, Zaida
  • Fernandez Martinez, Beatriz
  • Figuerola, Jordi
  • Gangoso, Laura
  • Vazquez, Ana
  • Gomez-Barroso, Diana
Introduction/objective: West Nile virus (WNV) is one of the most widely distributed flaviviruses worldwide. It is considered an endemic and emerging pathogen in different areas of the Europe and Mediterranean countries (MR). Mosquitoes of the genus Culex spp. are the main vectors, and birds its main vertebrate hosts. It can occasionally infect mammals, including humans. Different environmental factors can influence its distribution and transmission through its effects on vector or host populations. Our objective was to determine environmental factors associated with changes in vector distribution and WNV transmission in Europe and MR. Material & methods: Systematic peer review of articles published between 2000 and 2020. We selected studies on WNV, and its vectors carried out in Europe and MR. The search included terms referring to climatic and environmental factors. Results: We included 65 studies, of which 21 (32%) were conducted in Italy. Culex spp. was studied in 26 papers (40%), humans in 19 papers (29%) and host animals (mainly horses) in 16 papers (25%), whereas bird reservoirs were addressed in 5 studies (8%). A significant positive relationship was observed between changes in temperature and precipitation patterns and the epidemiology of WNV, although contrasting results were found among studies. Other factors positively related to WNV dynamics were the normalized difference vegetation index (NDVI] and expansion of anthropized habitats. Conclusion: The epidemiology of WNV seems to be related to climatic factors that are changing globally due to ongoing climate change. Unfortunately, the complete zoonotic cycle was not analyzed in most papers, making it difficult to determine the independent impact of environment on the different components of the transmission cycle. Given the current expansion and endemicity of WNV in the area, it is important to adopt holistic approaches to understand WNV epidemiology and to improve WNV surveillance and control.
Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

Dispersal history of SARS‐CoV‐2 in Galicia, Spain

  • Gallego Garcia, Maria Del Pilar
  • Estevez Gomez, Nuria
  • De Chiara Prada, Loretta
  • Alvariño Sanjurjo, Pilar
  • Juiz González, Pedro M.
  • Torres Beceiro, Isabel
  • Poza, Margarita
  • Vallejo, Juan A.
  • Rumbo Feal, Soraya
  • Conde Pérez, Kelly
  • Aja Macaya, Pablo
  • Ladra, Susana
  • Moreno Flores, Antonio
  • Gude González, María J.
  • Coira, Amparo
  • Aguilera, Antonio
  • Costa Alcalde, José J.
  • Trastoy, Rocío
  • Barbeito Castiñeiras, Gema
  • Garcia Souto, Daniel
  • Tubio, José M. C.
  • Trigo Daporta, Matilde
  • Camacho Zamora, Pablo
  • Costa, Juan García
  • González Domínguez, María
  • Canoura Fernández, Luis
  • González Peña, Daniel
  • Pérez Castro, Sonia
  • Cabrera, Jorge J.
  • Daviña Núñez, Carlos
  • Godoy Diz, Montserrat
  • Treinta Álvarez, Ana Belén
  • Veiga, Maria Isabel
  • Sousa, João Carlos
  • Osório, Nuno S.
  • Comas, Iñaki
  • González Candelas, Fernando
  • Hong, Samuel L.
  • Bollen, Nena
  • Dellicour, Simon
  • Baele, Guy
  • Suchard, Marc A.
  • Lemey, Philippe
  • Agulla, Andrés
  • Bou, Germán
  • Alonso García, Pilar
  • Pérez del Molino, María Luisa
  • García Campello, Marta
  • Paz Vidal, Isabel
  • Regueiro, Benito
  • Posada González, David
The dynamics of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) transmission are influenced by a variety of factors, including social restrictions and the emergence of distinct variants. In this study, we delve into the origins and dissemination of the Alpha, Delta, and Omicron‐BA.1 variants of concern in Galicia, northwest Spain. For this, we leveraged genomic data collected by the EPICOVIGAL Consortium and from the GISAID database, along with mobility information from other Spanish regions and foreign countries. Our analysis indicates that initial introductions during the Alpha phase were predominantly from other Spanish regions and France. However, as the pandemic progressed, introductions from Portugal and the United States became increasingly significant. The number of detected introductions varied from 96 and 101 for Alpha and Delta to 39 for Omicron‐BA.1. Most of these introductions left a low number of descendants (<10), suggesting a limited impact on the evolution of the pandemic in Galicia. Notably, Galicia's major coastal cities emerged as critical hubs for viral transmission, highlighting their role in sustaining and spreading the virus. This research emphasizes the critical role of regional connectivity in the spread of SARS‐CoV‐2 and offers essential insights for enhancing public health strategies and surveillance measures., Xunta de Galicia
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Dispersal History of SARS-CoV-2 in Galicia, Spain

  • Gallego-García, Pilar
  • Estévez‐Gómez, Nuria
  • Alvariño Alvariño, Pilar
  • Torres Beceiro, Isabel
  • Poza, Margarita
  • Vallejo, J. A.
  • Rumbo-Feal, Soraya
  • Conde-Pérez, Kelly
  • Aja-Macaya, Pablo
  • Ladra, Susana
  • Bou, Germán
Financiado para publicación en acceso aberto: Universidade de Vigo/CRUE-CISUG, All genome sequences and associated metadata in this dataset arepublished in GISAID's EpiCoV database. To view the contributors of each individual sequence with details such as accession number, Virus name,Collection date, Originating Lab, Submitting Lab, and the list of Authors,visit https://epicov.org/epi3/epi_set/240124ms (EPI_SET_ID: EPI_-SET_240124ms, Supporting Information: Table 3). The data that supportthe findings of this study are openly available in GISAID's EPICoVdatabase at https://gisaid.org/, reference number EPI_SET_240124ms., [Abstract] The dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission are influenced by a variety of factors, including social restrictions and the emergence of distinct variants. In this study, we delve into the origins and dissemination of the Alpha, Delta, and Omicron-BA.1 variants of concern in Galicia, northwest Spain. For this, we leveraged genomic data collected by the EPICOVIGAL Consortium and from the GISAID database, along with mobility information from other Spanish regions and foreign countries. Our analysis indicates that initial introductions during the Alpha phase were predominantly from other Spanish regions and France. However, as the pandemic progressed, introductions from Portugal and the United States became increasingly significant. The number of detected introductions varied from 96 and 101 for Alpha and Delta to 39 for Omicron-BA.1. Most of these introductions left a low number of descendants (<10), suggesting a limited impact on the evolution of the pandemic in Galicia. Notably, Galicia's major coastal cities emerged as critical hubs for viral transmission, highlighting their role in sustaining and spreading the virus. This research emphasizes the critical role of regional connectivity in the spread of SARS-CoV-2 and offers essential insights for enhancing public health strategies and surveillance measures., We gratefully acknowledge all data contributors, that is, the Authorsand their Originating laboratories responsible for obtaining thespecimens and their Submitting laboratories for generating the genetic sequence and metadata and sharing via the GISAID Initiative, on whichthis research is based. This work was funded by grant EPICOVIGAL FONDO SUPERA-COVID19 from Banco Santander-CSIC-CRUE andgrant CT850A‐2 from ACIS SERGAS from the Consellería de SanidadeXunta de Galicia. PGG was supported by grant ED481A‐2021/345 from the Consellería de Cultura, Educación e Universidade Xunta de Galicia. SD acknowledges support from the Fonds National de la Recherche Scientifique (F.R.S.‐FNRS, Belgium; grant no. F.4515.22). SD and GB acknowledge support from the Research Foundation ‐Flanders (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen, FWO, Belgium; grant no. G098321N) and from the European Union Horizon RIA 2023 project LEAPS (grant no. 101094685). GB acknowledges support from the Internal Funds KU Leuven (Grant No. C14/18/094), from the Research Foundation—Flanders (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen, FWO, Belgium; grant no. G0E1420N) and fromthe DURABLE EU4 Health project 02/2023‐01/2027, which is co‐funded by the European Union (call EU4H‐2021‐PJ4; grant no.101102733). SD and PL acknowledge support from the European Union Horizon 2020 project MOOD (grant agreement no. 874850). PL and MAS acknowledge support from the European Union's Horizon2020 research and innovation programme (grant agreement no. 725422—ReservoirDOCS), from the Wellcome Trust through project 206298/Z/17/Z and from the National Institutes of Health grants R01 AI153044, R01 AI162611 and U19 AI135995. PL also acknowledges support from the Research Foundation—Flanders (Fonds voor Wetenschappelijk Onderzoek—Vlaanderen, G0D5117N, and G051322N); MIV, JCS, and NSO acknowledge support from the Foundation for Science and Technology (FCT) (project UIDB/50026/2020, UIDP/50026/2020). Funding for open access charge: Universi-dade de Vigo/CRUE‐CISUG, Xunta de Galicia; CT850A‐2, Xunta de Galicia; ED481A‐2021/345, Belgique. Fonds de la recherche scientifique; F.4515.22, Belgique. Fonds voor Wetenschappelijk Onderzoek–Vlaanderen; G098321N, Belgique. Fonds voor Wetenschappelijk Onderzoek–Vlaanderen; G0D5117N, Belgique. Fonds voor Wetenschappelijk Onderzoek–Vlaanderen; G051322N, Foundation for Science and Technology (United Kingdom); UIDB/50026/2020, Foundation for Science and Technology (United Kingdom); UIDP/50026/2020, Katholieke Universiteit Leuven; C14/18/094, Wellcome Trust; 206298/Z/17/Z, United States. National Institutes of Health; R01 AI153044, United States. National Institutes of Health; R01 AI162611, United States. National Institutes of Health; U19 AI135995
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Anatomy of digital contact tracing: role of age, transmission setting, adoption and case detection

  • Moreno López, Jesús A.
  • Arregui García, Beatriz
  • Bentkowski, Piotr
  • Bioglio, Livio
  • Pinotti, Francesco
  • Boëlle, Pierre-Yves
  • Barrat, Alain
  • Colizza, Vittoria
  • Poletto, Chiara
The efficacy of digital contact tracing against COVID-19 epidemic is debated: smartphone penetration is limited in many countries, non-uniform across age groups, with low coverage among elderly, the most vulnerable to SARS-CoV-2. We developed an agent-based model to precise the impact of digital contact tracing and household isolation on COVID-19 transmission. The model, calibrated on French population, integrates demographic, contact-survey and epidemiological information to describe the risk factors for exposure and transmission of COVID-19. We explored realistic levels of case detection, app adoption, population immunity and transmissibility. Assuming a reproductive ratio R = 2.6 and 50% detection of clinical cases, a ~20% app adoption reduces peak incidence by ~35%. With R = 1.7, >30% app adoption lowers the epidemic to manageable levels. Higher coverage among adults, playing a central role in COVID-19 transmission, yields an indirect benefit for elderly. These results may inform the inclusion of digital contact tracing within a COVID-19 response plan., This study was partially supported by the ANR project DATAREDUX (ANR-19-CE46-0008-01) to AB, VC and PYB; EU H2020 grants MOOD (H2020-874850) to VC, CP, and PYB, and RECOVER (H2020-101003589) to VC; the Municipality of Paris (https://www.paris.fr/) through the programme Emergence(s) to JAML, BAG, PB, FP and CP; the ANR and Fondation de France through the project NoCOV (00105995) to PYB, CP; the Spanish Ministry of Science and Innovation to JAML and BAG, the AEI and FEDER (EU) under the grant PACSS (RTI2018-093732-B-C22) JAML and BAG; the Maria de Maeztu program for Units of Excellence in R&D (MDM-2017-0711) to JAML and BAG., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Anatomy of digital contact tracing: Role of age, transmission setting, adoption, and case detection

  • Moreno López, Jesús A.
  • Arregui García, Beatriz
  • Bentkowski, Piotr
  • Bioglio, Livio
  • Pinotti, Francesco
  • Boëlle, Pierre-Yves
  • Barrat, Alain
  • Colizza, Vittoria
  • Poletto, Chiara
The efficacy of digital contact tracing against coronavirus disease 2019 (COVID-19) epidemic is debated: Smartphone penetration is limited in many countries, with low coverage among the elderly, the most vulnerable to COVID-19. We developed an agent-based model to precise the impact of digital contact tracing and household isolation on COVID-19 transmission. The model, calibrated on French population, integrates demographic, contact and epidemiological information to describe exposure and transmission of COVID-19. We explored realistic levels of case detection, app adoption, population immunity, and transmissibility. Assuming a reproductive ratio R = 2.6 and 50% detection of clinical cases, a ~20% app adoption reduces peak incidence by ~35%. With R = 1.7, >30% app adoption lowers the epidemic to manageable levels. Higher coverage among adults, playing a central role in COVID-19 transmission, yields an indirect benefit for the elderly. These results may inform the inclusion of digital contact tracing within a COVID-19 response plan., This study was partially supported by the ANR project DATAREDUX (ANR-19-CE46-0008-01) to A.B., V.C., and P.-Y.B.; EU H2020 grants MOOD (H2020-874850) to V.C., C.P., and P.-Y.B. and RECOVER (H2020-101003589) to V.C.; the Municipality of Paris (www.paris.fr/) through the program Emergence(s) to J.A.M.L., B.A.G., P.B., F.P., and C.P.; the ANR and Fondation de France through the project NoCOV (00105995) to P.-Y.B. and C.P.; the Spanish Ministry of Science and Innovation to J.A.M.L. and B.A.G.; the AEI and FEDER (EU) under the grant PACSS (RTI2018-093732-B-C22) J.A.M.L. and B.A.G.; and the Maria de Maeztu program for Units of Excellence in R&D (MDM-2017-0711) to J.A.M.L. and B.A.G., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Dispersal history of SARS-CoV-2 in Galicia, Spain

  • Gallego-García, Pilar
  • Estévez-Gómez, Nuria
  • De Chiara, Loretta
  • Alvariño, Pilar
  • Juiz-González, Pedro M.
  • Torres-Beceiro, Isabel
  • Poza, Margarita
  • Vallejo, Juan A.
  • Rumbo-Feal, Soraya
  • Conde-Pérez, Kelly
  • Aja-Macaya, Pablo
  • Ladra, Susana
  • Moreno-Flores, Antonio
  • Gude-González, María J.
  • Coira, Amparo
  • Aguilera, Antonio
  • Costa-Alcalde, José J.
  • Trastoy, Rocío
  • Barbeito-Castiñeiras, Gema
  • García-Souto, Daniel
  • Tubio, José M. C.
  • Trigo-Daporta, Matilde
  • Camacho-Zamora, Pablo
  • García Costa, Juan
  • González-Domínguez, María
  • Canoura-Fernández, Luis
  • Glez-Peña, Daniel
  • Pérez-Castro, Sonia
  • Cabrera, Jorge J.
  • Daviña-Núñez, Carlos
  • Godoy-Diz, Montserrat
  • Treinta-Álvarez, Ana Belén
  • Veiga, María Isabel
  • Sousa, João Carlos
  • Osório, Nuno S.
  • Comas, Iñaki
  • González-Candelas, Fernando
  • Hong, Samuel L.
  • Bollen, Nena
  • Dellicour, Simon
  • Baele, Guy
  • Suchard, Marc A.
  • Lemey, Philippe
  • Agulla, Andrés
  • Bou, Germán
  • Alonso-García, Pilar
  • Pérez-del-Molino, María Luisa
  • García-Campello, Marta
  • Paz-Vidal, Isabel
  • Regueiro, Benito
  • Posada, David
The dynamics of SARS-CoV-2 transmission are influenced by a variety of factors, including social restrictions and the emergence of distinct variants. In this study, we delve into the origins and dissemination of the Alpha, Delta, and Omicron variants of concern in Galicia, northwest Spain. For this, we leveraged genomic data collected by the EPICOVIGAL Consortium and from the GISAID database, along with mobility information from other Spanish regions and foreign countries. Our analysis indicates that initial introductions during the Alpha phase were predominantly from other Spanish regions and France. However, as the pandemic progressed, introductions from Portugal and the USA became increasingly significant. Notably, Galicia’s major coastal cities emerged as critical hubs for viral transmission, highlighting their role in sustaining and spreading the virus. This research emphasizes the critical role of regional connectivity in the spread of SARS-CoV-2 and offers essential insights for enhancing public health strategies and surveillance measures., This work was funded by grant EPICOVIGAL FONDO SUPERA-COVID19 from Banco Santander-CSIC-CRUE and grant CT850A-2 from ACIS SERGAS from the Consellería de Sanidade Xunta de Galicia. PGG was supported by grant ED481A-2021/345 from the Consellería de Cultura, Educación e Universidade Xunta de Galicia. SD acknowledges support from the Fonds National de la Recherche (F.R.S.-FNRS, Belgium; grant no. F.4515.22). SD and GB acknowledge support from the Research Foundation - Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen, FWO, Belgium; grant no. G098321N) and from the European Union Horizon RIA 2023 project LEAPS (grant no. 101094685). GB acknowledges support from the Internal Funds KU Leuven (Grant No. C14/18/094), from the Research Foundation - Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen, FWO, Belgium; grant no. G0E1420N) and from the DURABLE EU4Health project 02/2023-01/2027, which is co-funded by the European Union (call EU4H-2021-PJ4; grant no. 101102733). SD and PL acknowledge support from the European Union Horizon 2020 project MOOD (grant agreement no. 874850). PL and MAS acknowledge support from the European Union's Horizon 2020 research and innovation programme (grant agreement no. 725422 - ReservoirDOCS), from the Wellcome Trust through project 206298/Z/17/Z and from the National Institutes of Health grants R01 AI153044, R01 AI162611 and U19 AI135995. PL also acknowledges support from the Research Foundation - Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen, G0D5117N, and G051322N); MIV, JCS and NSO acknowledge support from the Foundation for Science and Technology (FCT) (project UIDB/50026/2020, UIDP/50026/2020)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dispersal history of SARS-CoV-2 in Galicia, Spain

  • Gallego-García, Pilar
  • Estévez-Gómez, Nuria
  • De Chiara, Loretta
  • Alvariño, Pilar
  • Juiz-González, Pedro M.
  • Torres-Beceiro, Isabel
  • Poza, Margarita
  • Vallejo, Juan A.
  • Rumbo-Feal, Soraya
  • Conde-Pérez, Kelly
  • Aja-Macaya, Pablo
  • Ladra, Susana
  • Moreno-Flores, Antonio
  • Gude-González, María J.
  • Coira, Amparo
  • Aguilera, Antonio
  • Costa-Alcalde, José J.
  • Trastoy, Rocío
  • Barbeito-Castiñeiras, Gema
  • García-Souto, Daniel
  • Tubio, José M. C.
  • Trigo-Daporta, Matilde
  • Camacho-Zamora, Pablo
  • García Costa, Juan
  • González-Domínguez, María
  • Canoura-Fernández, Luis
  • Glez-Peña, Daniel
  • Pérez-Castro, Sonia
  • Cabrera, Jorge J.
  • Daviña-Núñez, Carlos
  • Godoy-Diz, Montserrat
  • Treinta-Álvarez, Ana Belén
  • Veiga, María Isabel
  • Sousa, João Carlos
  • Osório, Nuno S.
  • Comas, Iñaki
  • González-Candelas, Fernando
  • Hong, Samuel L.
  • Bollen, Nena
  • Dellicour, Simon
  • Baele, Guy
  • Suchard, Marc A.
  • Lemey, Philippe
  • Agulla, Andrés
  • Bou, Germán
  • Alonso-García, Pilar
  • Pérez-del-Molino, María Luisa
  • García-Campello, Marta
  • Paz-Vidal, Isabel
  • Regueiro, Benito
  • Posada, David
13 páginas, 4 figuras, The dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission are influenced by a variety of factors, including social restrictions and the emergence of distinct variants. In this study, we delve into the origins and dissemination of the Alpha, Delta, and Omicron-BA.1 variants of concern in Galicia, northwest Spain. For this, we leveraged genomic data collected by the EPICOVIGAL Consortium and from the GISAID database, along with mobility information from other Spanish regions and foreign countries. Our analysis indicates that initial introductions during the Alpha phase were predominantly from other Spanish regions and France. However, as the pandemic progressed, introductions from Portugal and the United States became increasingly significant. The number of detected introductions varied from 96 and 101 for Alpha and Delta to 39 for Omicron-BA.1. Most of these introductions left a low number of descendants (<10), suggesting a limited impact on the evolution of the pandemic in Galicia. Notably, Galicia's major coastal cities emerged as critical hubs for viral transmission, highlighting their role in sustaining and spreading the virus. This research emphasizes the critical role of regional connectivity in the spread of SARS-CoV-2 and offers essential insights for enhancing public health strategies and surveillance measures., This work was funded by grant EPICOVIGAL FONDO SUPERA-COVID19 from Banco Santander-CSIC-CRUE and grant CT850A-2 from ACIS SERGAS from the Consellería de Sanidade Xunta de Galicia. PGG was supported by grant ED481A-2021/345 from the Consellería de Cultura, Educación e Universidade Xunta de Galicia. SD acknowledges support from the Fonds National de la Recherche (F.R.S.-FNRS, Belgium; grant no. F.4515.22). SD and GB acknowledge support from the Research Foundation - Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen, FWO, Belgium; grant no. G098321N) and from the European Union Horizon RIA 2023 project LEAPS (grant no. 101094685). GB acknowledges support from the Internal Funds KU Leuven (Grant No. C14/18/094), from the Research Foundation - Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen, FWO, Belgium; grant no. G0E1420N) and from the DURABLE EU4Health project 02/2023-01/2027, which is co-funded by the European Union (call EU4H-2021-PJ4; grant no. 101102733). SD and PL acknowledge support from the European Union Horizon 2020 project MOOD (grant agreement no. 874850). PL and MAS acknowledge support from the European Union's Horizon 2020 research and innovation programme (grant agreement no. 725422 - ReservoirDOCS), from the Wellcome Trust through project 206298/Z/17/Z and from the National Institutes of Health grants R01 AI153044, R01 AI162611 and U19 AI135995. PL also acknowledges support from the Research Foundation - Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen, G0D5117N, and G051322N); MIV, JCS and NSO acknowledge support from the Foundation for Science and Technology (FCT) (project UIDB/50026/2020, UIDP/50026/2020)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Multidisciplinary tracking of highly pathogenic avian influenza A(H5N1) outbreak in Griffon vultures, Southern Europe, 2022

  • Hirschinger, Julien
  • Höfle, Ursula
  • Sánchez-Cano, Alberto
  • Guinat, Claire
  • Barral, Marta
  • Donázar, José A.
  • Álvarez, Vega
  • Gerrikagoitia, Xeider
  • Arrondo, Eneko
  • Sánchez-Zapata, José A.
  • Cortés-Avizanda, Ainara
  • Minayo Martín, Sara
  • Le Loc’h, Guillaume
et al., Since 2021, highly pathogenic avian influenza (HPAI) A(H5N1) clade 2.3.4.4b virus has affected wild bird populations globally. Griffon vultures (Gyps fulvus), a species hitherto considered unexposed, experienced an HPAI H5N1 outbreak in 2022 in southern Europe, leading to moderate mortality and reduced breeding success. The integration of virological, serologic, phylogenetic, and ecologic data revealed a short yet intense viral circulation and a probable common source of infection. The dissemination across Spain and France was likely caused by frequent interpopulation movements of birds. This integrated overview of the 2022 HPAI outbreak in vultures provides novel insights into the role of large-scale movements of wild birds in the spread of such disease. Understanding the epidemiologic dynamics of HPAI H5N1 in these scavenger species is crucial because the birds play vital roles in ecosystem functioning. Their susceptibility to this virus highlights potential broader ecologic effects of the ongoing outbreaks., E.N.V.T. participated in the framework of the “Chaire de Biosécurité et Santé Aviaires,” funded by the Direction Générale de l’Alimentation, Ministère de l’Agriculture et de la Souveraineté Alimentaire, France. S.D. acknowledges support from the Fonds National de la Recherche Scientifique (F.R.S.-FNRS, Belgium; grant no. F.4515.22), from the Research Foundation–Flanders (Fonds voor Wetenschappelijk Onderzoek — Vlaanderen, FWO, Belgium; grant no. G098321N), and from the European Union Horizon 2020 projects MOOD (grant agreement no. 874850) and LEAPS (grant agreement no. 101094685). E.A. was supported by MCIN/AEI/10.13039/501100011033 grant nos. FJC2021-047885-I. The sampling and analyses carried out at NEIKER have been financed by MCIN/AEI/10.13039/501100011033 (grant no. PID2020-114060RR-C31) and by Basque Government (grant no. VIGIA-2200003). Analysis carried out at IREC was supported byMCIN/AEI/10.13039/501100011033 (grant no. PID2020-114060RR-C32). Monitoring of the GPS-tagged birds in Spain was funded by the Comunidad de Bardenas Reales de Navarra and the Projects RNM-1925 and P18-RT-1321 (Junta de Andalucía), and Ecotone Telemetry 2017-12-026., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Modelling the risk posed by Aedes mosquitoes in Europe: Identifying research needs from public health stakeholders and field entomologists

  • Romiti, Federico
  • Droghei, Sarah
  • Brass, Dominic
  • Caminade, Cyril
  • Marini, Giovanni
  • Purse, Bethan V.
  • Erguler, Kamil
  • Albieri, Alessandro
  • Angelini, Paola
  • Blaha, Margo
  • Briet, Olivier
  • Calzolari, Mattia
  • Carrieri, Marco
  • D'Alessio, Silvio
  • Ferraguti, Martina
  • Ferrari, Nicola
  • Fesce, Elisa
  • Flacio, Eleonora
  • Zornoza, Miguel Garrido
  • Hammami, Pachka
  • Huxley, Paul J
  • Ibáñez-Justicia, Adolfo
  • Ippoliti, Carla
  • Kern, Emmanuelle
  • Longo, Eleonora
  • Meyer, Alexander
  • Müller, Ruth
  • Pardo, Marta
  • Reuss, Friederike
  • Santarelli, Greta
  • Sprengers, Lukas
  • Thomas, Stephanie Margarete
  • Van Bortel, Wim
  • Virgilito, Chiara
  • Wang, Yiran
  • Wint, William
  • Rosà, Roberto
  • Da Re, Daniele
The growing public health burden of Aedes mosquito-borne diseases requires a comprehensive understanding of Aedes species biology, ecology, and vector competence. Eco-epidemiological modelling of Aedes vector species has grown significantly in recent years, driven by the increasing reports of outbreaks in endemic and non-endemic temperate areas, as well as the latitudinal and altitudinal range expansion of these vectors. A prominent example is the Asian tiger mosquito, Aedes albopictus, a competent arbovirus vector that has spread across most continents through the movement of humans and goods. Species distribution models and mechanistic models have been used to predict the spatio-temporal distribution and dynamics of this vector. However, despite the potential of these models to capture the vector distribution and dynamics, integrating them into practical monitoring, surveillance, and vector control activities remains challenging, often due to a lack of communication and model co-development between scientists and public health stakeholders. This paper reports the results of a workshop on vector modelling held in Bologna (Italy) in September 2024, which brought together European experts in disease modelling, public health stakeholders, and medical entomologists. The workshop identified key priorities for advancing the operational use of Aedes-focused quantitative models, including sustained investment in surveillance, improved representation of environmental and biological drivers, standardisation of model outputs, and the establishment of long-term, co-produced modelling frameworks embedded within public health workflows., Financial support for the first “Climate-Sensitive Vector Dynamics Modelling Workshop was provided by Wellcome through the VEClim project (grant no. 226065), funded under the Digital Technology Development Awards in Climate-Sensitive Infectious Disease Modelling, and by the University of Trento through the Italian Ministry of University and Research grant PRIN 2020 MosqIT “Tackling mosquitoes in Italy: from citizen to bench and back” (N. 2020XYBN88)., Daniele Da Re was supported by the Marie Sklodowska-Curie Actions - Postdoctoral fellowship Nr. 101106664. Nicola Ferrari and Elisa Fesce were supported by the Multilayered Urban Sustainability Action (MUSA) project, funded by European Union–NextGenerationEU, under the National Recovery and Resilience Plan (NRRP) Mission 4 Component 2 Investment Line 1.5: Strengthening of research structures and creation of R&D “innovation ecosystems”, set up of “territorial leaders in R&D” and partially supported by UNIMI GSA-IDEA Project. Martina Ferraguti was supported by project PID2022-142803OA-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE. William Wint was supported by the Horizon 2020 MOOD Project (GA 874850). Stephanie Thomas was supported by BayByeMos project (AP-2411-PN 21–14-V3-D22827/2022) within the Joint Project “Climate Change and Health II” (VKG II). Roberto Rosà and Margo Blaha were supported by the the Italian Ministry of University and Research grant PRIN 2020 MosqIT “Tackling mosquitoes in Italy: from citizen to bench and back” (N. 2020XYBN88). Paul Huxley was supported by Wellcome Trust (213494/Z/18/Z). Ruth Müller was supported by the Human Frontiers Science Program (HFSP -RGP0044/2021). Wim Van Bortel, belonging to the The Outbreak Research team of the Institute of Tropical Medicine is financially supported by the Department of Economy, Science and Innovation of the Flemish government. Yiran Wang acknowledges funding from the NERC Grantham Institute SSCP DTP (grant number NE/S007415/1)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients

  • Gonçalves, Bronner P.
  • Gómez Junyent, Joan
  • Olliaro Piero L.
  • ISARIC Clinical Characterisation Group
Background: whilst timely clinical characterisation of infections caused by novel SARS-CoV-2 variants is necessary for evidence-based policy response, individual-level data on infecting variants are typically only available for a minority of patients and settings. Methods: here, we propose an innovative approach to study changes in COVID-19 hospital presentation and outcomes after the Omicron variant emergence using publicly available population-level data on variant relative frequency to infer SARS-CoV-2 variants likely responsible for clinical cases. We apply this method to data collected by a large international clinical consortium before and after the emergence of the Omicron variant in different countries. Results: our analysis, that includes more than 100,000 patients from 28 countries, suggests that in many settings patients hospitalised with Omicron variant infection less often presented with commonly reported symptoms compared to patients infected with pre-Omicron variants. Patients with COVID-19 admitted to hospital after Omicron variant emergence had lower mortality compared to patients admitted during the period when Omicron variant was responsible for only a minority of infections (odds ratio in a mixed-effects logistic regression adjusted for likely confounders, 0.67 [95% confidence interval 0.61-0.75]). Qualitatively similar findings were observed in sensitivity analyses with different assumptions on population-level Omicron variant relative frequencies, and in analyses using available individual-level data on infecting variant for a subset of the study population. Conclusions: although clinical studies with matching viral genomic information should remain a priority, our approach combining publicly available data on variant frequency and a multi-country clinical characterisation dataset with more than 100,000 records allowed analysis of data from a wide range of settings and novel insights on real-world heterogeneity of COVID-19 presentation and clinical outcome., Bronner P. Gonçalves, Peter Horby, Gail Carson, Piero L. Olliaro, Valeria Balan, Barbara Wanjiru Citarella, and research costs were supported by the UK Foreign, Commonwealth and Development Office (FCDO) and Wellcome [215091/Z/18/Z, 222410/Z/21/Z, 225288/Z/22/Z]; and Janice Caoili and Madiha Hashmi were supported by the UK FCDO and Wellcome [222048/Z/20/Z]. Peter Horby, Gail Carson, Piero L. Olliaro, Kalynn Kennon and Joaquin Baruch were supported by the Bill & Melinda Gates Foundation [OPP1209135]; Laura Merson was supported by University of Oxford's COVID-19 Research Response Fund - with thanks to its donors for their philanthropic support. Matthew Hall was supported by a Li Ka Shing Foundation award to Christophe Fraser. Moritz U.G. Kraemer was supported by the Branco Weiss Fellowship, Google.org, the Oxford Martin School, the Rockefeller Foundation, and the European Union Horizon 2020 project MOOD (#874850). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. Contributions from Srinivas Murthy, Asgar Rishu, Rob Fowler, James Joshua Douglas, François Martin Carrier were supported by CIHR Coronavirus Rapid Research Funding Opportunity OV2170359 and coordinated out of Sunnybrook Research Institute. Contributions from Evert-Jan Wils and David S.Y. Ong were supported by a grant from foundation Bevordering Onderzoek Franciscus; and Andrea Angheben by the Italian Ministry of Health "Fondi Ricerca corrente-L1P6" to IRCCS Ospedale Sacro Cuore-Don Calabria. The data contributions of J.Kenneth Baillie, Malcolm G. Semple, and Ewen M. Harrison were supported by grants from the National Institute for Health Research (NIHR; award CO-CIN-01), the Medical Research Council (MRC; grant MC_PC_19059), and by the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE) (award 200907), NIHR HPRU in Respiratory Infections at Imperial College London with PHE (award 200927), Liverpool Experimental Cancer Medicine Centre (grant C18616/A25153), NIHR Biomedical Research Centre at Imperial College London (award IS-BRC-1215-20013), and NIHR Clinical Research Network providing infrastructure support. All funders of the ISARIC Clinical Characterisation Group are listed in the appendix.
Docta Complutense
Publication Artículo científico (JournalArticle)

A systematic review of environmental factors related to WNV circulation in European and Mediterranean countries

  • Giesen, Christine
  • Herrador, Zaida
  • Fernandez-Martinez, Beatriz
  • Figuerola, Jordi
  • Gangoso De La Colina, Laura Esther
  • Vazquez, Ana
  • Gómez-Barroso, Diana
Introduction/objective: West Nile virus (WNV) is one of the most widely distributed flaviviruses worldwide. It is considered an endemic and emerging pathogen in different areas of the Europe and Mediterranean countries (MR). Mosquitoes of the genus Culex spp. are the main vectors, and birds its main vertebrate hosts. It can occasionally infect mammals, including humans. Different environmental factors can influence its distribution and transmission through its effects on vector or host populations. Our objective was to determine environmental factors associated with changes in vector distribution and WNV transmission in Europe and MR. Material & methods: Systematic peer review of articles published between 2000 and 2020. We selected studies on WNV, and its vectors carried out in Europe and MR. The search included terms referring to climatic and environmental factors. Results: We included 65 studies, of which 21 (32%) were conducted in Italy. Culex spp. was studied in 26 papers (40%), humans in 19 papers (29%) and host animals (mainly horses) in 16 papers (25%), whereas bird reservoirs were addressed in 5 studies (8%). A significant positive relationship was observed between changes in temperature and precipitation patterns and the epidemiology of WNV, although contrasting results were found among studies. Other factors positively related to WNV dynamics were the normalized difference vegetation index (NDVI] and expansion of anthropized habitats. Conclusion: The epidemiology of WNV seems to be related to climatic factors that are changing globally due to ongoing climate change. Unfortunately, the complete zoonotic cycle was not analyzed in most papers, making it difficult to determine the independent impact of environment on the different components of the transmission cycle. Given the current expansion and endemicity of WNV in the area, it is important to adopt holistic approaches to understand WNV epidemiology and to improve WNV surveillance and control.